Protein release from poly(lactide-co-glycolide) implants prepared by hot-melt extrusion: Thioester formation as a reason for incomplete release

被引:41
作者
Ghalanbor, Zahra [1 ]
Koerber, Martin [1 ]
Bodmeier, Roland [1 ]
机构
[1] Free Univ Berlin, Coll Pharm, D-12169 Berlin, Germany
关键词
Biodegradable implant; Hot melt extrusion; Poly(lactide-co-glycolide); Protein formulation; Incomplete release; BOVINE SERUM-ALBUMIN; PLGA MICROSPHERES; PEPTIDE ACYLATION; MICROPARTICLES; INSTABILITY; DEGRADATION; STABILITY; MODEL;
D O I
10.1016/j.ijpharm.2012.09.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to characterize the protein release from PLGA-based implants prepared by hot-melt extrusion with special emphasis on identifying reasons for incomplete release. Biodegradable PLGA-implants loaded with BSA were prepared with a syringe-die extrusion device. A burst-free release was achieved up to 25% BSA loading by milling the protein prior to extrusion. The release was incomplete at 70% at loadings below the percolation threshold of the protein; higher protein loadings increased the release to 97%. However, an insoluble implant mass remained for over 180 days, which was attributed to the acylation of BSA by PLGA oligomers via a thioester bond. The incomplete protein release due to the formation of this covalent bond was overcome when increasing the porosity of the implant, which effectively reduced the contact between BSA and PLGA oligomers. Accordingly, melt-extrusion facilitated incorporating high loadings of BSA into burst-free biodegradable implants. Additionally, it enhanced complete protein release by a process- or formulation controlled increase of the implant porosity. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:302 / 306
页数:5
相关论文
共 22 条
[1]   Pharmaceutical applications of hot-melt extrusion: Part I [J].
Crowley, Michael M. ;
Zhang, Feng ;
Repka, Michael A. ;
Thumma, Sridhar ;
Upadhye, Sampada B. ;
Battu, Sunil Kumar ;
McGinity, James W. ;
Martin, Charles .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2007, 33 (09) :909-926
[2]   BSA degradation under acidic conditions: A model for protein instability during release from PLGA delivery systems [J].
Estey, Tia ;
Kang, Jichao ;
Schwendeman, Steven P. ;
Carpenter, John F. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (07) :1626-1639
[3]   ANALYSIS OF BIOLOGICAL THIOLS - DETERMINATION OF THIOL COMPONENTS OF DISULFIDES AND THIOESTERS [J].
FENTON, SS ;
FAHEY, RC .
ANALYTICAL BIOCHEMISTRY, 1986, 154 (01) :34-42
[4]   Protein drug stability: A formulation challenge [J].
Frokjaer, S ;
Otzen, DE .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (04) :298-306
[5]  
Ghalanbor Z., INTERDEPENDENC UNPUB
[6]   Improved Lysozyme Stability and Release Properties of Poly(lactide-co-glycolide) Implants Prepared by Hot-Melt Extrusion [J].
Ghalanbor, Zahra ;
Koerber, Martin ;
Bodmeier, Roland .
PHARMACEUTICAL RESEARCH, 2010, 27 (02) :371-379
[7]   How to achieve sustained and complete protein release from PLGA-based microparticles? [J].
Giteau, A. ;
Venier-Julienne, M. C. ;
Aubert-Pouessel, A. ;
Benoit, J. P. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 350 (1-2) :14-26
[8]   Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres [J].
Kim, JH ;
Taluja, A ;
Knutson, K ;
Bae, YH .
JOURNAL OF CONTROLLED RELEASE, 2005, 109 (1-3) :86-100
[9]   Modification of the tri-phasic drug release pattern of leuprolide acetate-loaded poly(lactide-co-glycolide) microparticles [J].
Luan, Xiaosong ;
Bodmeier, Roland .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 63 (02) :205-214
[10]   Peptide acylation by poly(α-hydroxy esters) [J].
Lucke, A ;
Kiermaier, J ;
Göpferich, A .
PHARMACEUTICAL RESEARCH, 2002, 19 (02) :175-181